Literature DB >> 28537471

Characteristics of Labial Gland Mesenchymal Stem Cells of Healthy Individuals and Patients with Sjögren's Syndrome: A Preliminary Study.

Shi-Qin Wang1, Yi-Xiang Wang2, Hong Hua1.   

Abstract

Sjögren's syndrome (SS) is a systemic autoimmune disease that is characterized by focal lymphocytic infiltration into exocrine organs such as salivary and lacrimal glands, resulting in dry mouth and eyes, and other systemic injuries. There is no curative clinical therapy for SS, and stem cell therapy has shown great potential in this area. The mesenchymal stem cells (MSCs) in the salivary glands of healthy individuals and in patients with SS have not been extensively studied. The aim of this study was to elucidate the characteristics of MSCs from the labial glands of healthy controls and of those from patients with SS to elucidate the related pathogenesis and to uncover potential avenues for novel clinical interventions. Labial glands from patients with SS and healthy subjects were obtained, and MSCs were isolated and cultured by using the tissue adherent method. The MSC characteristics of the cultured cells were confirmed by using morphology, proliferation, colony forming-unit (CFU) efficiency, and multipotentiality, including osteogenic, adipogenic, and salivary gland differentiation. The MSCs from the healthy controls and SS patients expressed characteristic MSC markers, including CD29, CD44, CD73, CD90, and CD105; they were negative for CD34, CD45, and CD106, and also negative for the salivary gland epithelium markers (CD49f and CD117). Labial gland MSCs from both groups were capable of osteogenic and adipogenic differentiation. The CFU efficiency and adipogenic differentiation potential of MSCs were significantly lower in the SS group compared with the healthy controls. Cells from both groups could also be induced into salivary gland-like cells. Real-time polymerase chain reaction and immunofluorescence staining showed that the gene and protein expression of AMY1, AQP5, and ZO-1 in cells from the SS group was lower than that in cells from the healthy group. Thus, MSCs from the labial glands in patients with SS could lack certain characteristics and functions, especially related to salivary secretion. These preliminary data provided insights that could lead to the development of novel therapeutic strategies for the treatment of SS.

Entities:  

Keywords:  Sjögren's syndrome; labial glands; mesenchymal stem cells; salivary glands

Mesh:

Substances:

Year:  2017        PMID: 28537471     DOI: 10.1089/scd.2017.0045

Source DB:  PubMed          Journal:  Stem Cells Dev        ISSN: 1547-3287            Impact factor:   3.272


  7 in total

1.  Effect of Bone Morphogenetic Protein 6 on Immunomodulatory Functions of Salivary Gland-Derived Mesenchymal Stem Cells in Sjögren's Syndrome.

Authors:  Junji Xu; Yingying Su; Lei Hu; Alexander Cain; Yi Gu; Bowen Liu; Ruiqing Wu; Songlin Wang; Hao Wang
Journal:  Stem Cells Dev       Date:  2018-11-15       Impact factor: 3.272

2.  Minor salivary gland mesenchymal stromal cells derived from patients with Sjӧgren's syndrome deploy intact immune plasticity.

Authors:  Sara S McCoy; Jayeeta Giri; Rahul Das; Pradyut K Paul; Andrea Pennati; Maxwell Parker; Yun Liang; Jacques Galipeau
Journal:  Cytotherapy       Date:  2020-11-28       Impact factor: 5.414

3.  Adipose-mesenchymal stromal cells suppress experimental Sjögren syndrome by IL-33-driven expansion of ST2+ regulatory T cells.

Authors:  Ousheng Liu; Junji Xu; Fu Wang; Wenwen Jin; Peter Zanvit; Dandan Wang; Nathan Goldberg; Alexander Cain; Nancy Guo; Yichen Han; Andrew Bynum; Guowu Ma; Songlin Wang; Zhangui Tang; Wanjun Chen
Journal:  iScience       Date:  2021-04-16

4.  Mesenchymal Stem Cells Extract (MSCsE)-Based Therapy Alleviates Xerostomia and Keratoconjunctivitis Sicca in Sjogren's Syndrome-Like Disease.

Authors:  Ghada Abughanam; Osama A Elkashty; Younan Liu; Mohammed O Bakkar; Simon D Tran
Journal:  Int J Mol Sci       Date:  2019-09-25       Impact factor: 5.923

5.  Labial Gland Mesenchymal Stem Cell Derived Exosomes-Mediated miRNA-125b Attenuates Experimental Sjogren's Syndrome by Targeting PRDM1 and Suppressing Plasma Cells.

Authors:  Yixiao Xing; Boya Li; Jing He; Hong Hua
Journal:  Front Immunol       Date:  2022-04-04       Impact factor: 8.786

Review 6.  Mesenchymal Stem Cells in Primary Sjögren's Syndrome: Prospective and Challenges.

Authors:  Weiqian Chen; Ye Yu; Jilin Ma; Nancy Olsen; Jin Lin
Journal:  Stem Cells Int       Date:  2018-09-16       Impact factor: 5.443

Review 7.  A Synopsis of Signaling Crosstalk of Pericytes and Endothelial Cells in Salivary Gland.

Authors:  Ioana Cucu; Mihnea Ioan Nicolescu
Journal:  Dent J (Basel)       Date:  2021-12-01
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.